Home › Myriad Genetics Upgraded by Credit Suisse to "Neutral"
 

Keywords :   


Myriad Genetics Upgraded by Credit Suisse to "Neutral"

2014-02-09 03:19:34| Biotech - Topix.net

The firm currently has a $29.00 target price on the stock. Credit Suisse's price objective indicates a potential downside of 10.02% from the stock's previous close.

Tags: credit suisse neutral genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »